Dr. Weihua Cai is currently a Medical Director at ICON plc, where they provide medical support on patient safety and pharmacovigilance for various clinical trials and medications. They received their medical degree from Tianjin Medical University after completing an advanced eight-year medical course and have spent over six years focusing on internal medicine with a specialization in neurology. Before joining ICON plc in 2019, Dr. Cai accumulated extensive experience in pharmacovigilance and clinical research at major pharmaceutical companies in Japan, as well as significant expertise in basic life science research on intracellular signal transduction. They have contributed to various regulatory consulting services and have held leadership roles managing safety assessments in pharmacovigilance departments.
Location
Tokyo, Japan
This person is not in any teams
This person is not in any offices